CrossrefInfokarte
The AMPK-ALDH7A1 axis drives metabolic reprogramming and anti-tumor immunity in hepatocellular carcinoma via KDM5C inhibition
Developmental Cell · 2026-11 · 61 (11) · 2228-2246.e12
DOI: 10.1016/j.devcel.2026.10.006 ↗Abstract
Kein Abstract verfügbar.
EUVIMED